Clinical Trial Update: Safety and Efficiency Study of Valproic Acid In HAM/TSP [NA]

View source ↗

Summary

This clinical trial evaluated the safety and efficacy of valproic acid in HTLV-1-associated myelopathy (HAM/TSP) and has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1-associated Myelopathy

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University Hospital Pierre Zobda-Quitman | Conditions: HTLV-I-Associated Myelopathy | NA | Status: TERMINATED